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Background: The aim of this case–control study was to analyse the clinical characteristics of children with recurrent
community-acquired pneumonia (rCAP) affecting different lung areas (DLAs) and compare them with those of
children who have never experienced CAP in order to contribute to identifying the best approach to such patients.
Methods: The study involved 146 children with ≥2 episodes of radiographically confirmed CAP in DLA in a single year
(or ≥3 episodes in any time frame) with radiographic clearing of densities between occurrences, and 145 age- and
gender-matched controls enrolled in Milan, Italy, between January 2009 and December 2012. The demographic and
clinical characteristics of the cases and controls were compared, and a comparison was also made between the cases
with rCAP (i.e. ≤3 episodes) and those with highly recurrent CAP (hrCAP: i.e. >3 episodes).
Results: Gestational age at birth (p = 0.003), birth weight (p = 0.006), respiratory distress at birth (p < 0.001), and age
when starting day care attendance (p < 0.001) were significantly different between the cases and controls, and recurrent
infectious wheezing (p < 0.001), chronic rhinosinusitis with post-nasal drip (p < 0.001), recurrent upper respiratory tract
infections (p < 0.001), atopy/allergy (p < 0.001) and asthma (p < 0.001) were significantly more frequent. Significant risk
factors for hrCAP were gastroesophageal reflux disease (GERD; p = 0.04), a history of atopy and/or allergy (p = 0.005), and
a diagnosis of asthma (p = 0.0001) or middle lobe syndrome (p = 0.001). Multivariate logistic regression analysis, adjusted
for age and gender, showed that all of the risk factors other than GERD and wheezing were associated with hrCAP.
Conclusions: The diagnostic approach to children with rCAP in DLAs is relatively easy in the developed world, where
the severe chronic underlying diseases favouring rCAP are usually identified early, and patients with chronic underlying
disease are diagnosed before the occurrence of rCAP in DLAs. When rCAP in DLAs does occur, an evaluation of the
patients’ history and clinical findings make it possible to limit diagnostic investigations.
Keywords: Allergy, Asthma, Atopy, Children, Community-acquired pneumonia, Lower respiratory tract infection,
Pneumonia, Recurrent pneumonia, Respiratory tract infection, WheezingBackground
Recurrent community acquired pneumonia (rCAP) is not
rare in children living in industrialised countries. The Isle
of Wight birth cohort study of 1,336 children followed up
for 10 years found a 7.4% prevalence of ≥2 lower respi-
ratory tract infections (LRTIs) including CAP [1]; a retro-
spective cohort study of German children aged 5–7 years
found that 6.7-8.2% of the children had a positive history
of CAP, 6.9-8.2% of whom had experienced rCAP [2]; and* Correspondence: susanna.esposito@unimi.it
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reproduction in any medium, provided the ordata from Toronto’s Hospital for Sick Children show that
238 of 2,900 children (8%) admitted because of CAP met
the criteria for rCAP [3].
Identifying the factors that can favour the development
of a new CAP episode is critical for the implementation of
appropriate preventive, diagnostic and therapeutic mea-
sures. However, although it is relatively easy to evaluate
and treat cases occurring in the same lung region, it is
more difficult in the case of rCAP developing in different
lung areas (DLAs). Recurring lung densities in the same re-
gions are almost invariably due to intra- or extraluminal
bronchial obstruction, or structural abnormalities of the
airways or lung parenchyma, and the recommended airwaytd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ciation with laboratory tests for tuberculosis and fungal
diseases) is almost always sufficient to make a diagnosis
[4]. On the contrary, rCAP affecting multiple lobes or dif-
ferent areas of the same lobe may be associated with a wide
range of more or less severe clinical problems that could
per se increase the risk of lung infection. As some of these
can only be identified using specific laboratory and/or in-
strumental methods, diagnosing and treating patients with
rCAP in DLAs can be particularly complicated and expen-
sive, and is not always efficacious.
Various attempts have been made to define the most
frequent causes of rCAP and establish the most rational
diagnostic and therapeutic approach [5-9]. Unfortu-
nately, the findings are frequently conflicting, and it is
not possible to state whether the cause of rCAP in DLAs
is necessarily a serious underlying diseases requiring im-
mediate diagnosis.
The aim of this case–control study was to analyse the
demographic and clinical characteristics as well as the
predisposing factors of children with rCAP in DLAs and
compare them with those of children who had never ex-
perienced CAP in order to contribute to identifying the
best approach to such patients.
Patients and methods
Patients
We reviewed the medical records of all of the children aged
<14 years who attended the Respiratory Disease Section of
Pediatric Clinic 1, Department of Pathophysiology and
Transplantation, University of Milan, Fondazione IRCCS
Ca’ Granda, Ospedale Maggiore Policlinico, Milan,
Italy, between January 2009 and December 2012
because of rCAP. The patients were included in the
analysis if they had experienced ≥2 episodes of radio-
graphically confirmed CAP in a single year (or ≥3 epi-
sodes in any time frame) with radiographic clearing
of densities between occurrences [10]. Only the chil-
dren with rCAP in DLAs were enrolled, except for
those with a diagnosis of cystic fibrosis identified in
the first weeks of life who were excluded and followed
up in accordance with specific diagnostic and thera-
peutic guidelines. The controls were age- and gender-
matched children who had never experienced CAP,
and for whom all of the data concerning their health
problems since birth were available as they had been
continuously followed at the same institution for the
purpose of vaccinations and periodic evaluations of
growth and psychological development.
The study was approved by the Ethics Committee of
Fondazione IRCCS Ca’ Granda. Ospedale Maggiore
Policlinico, Milan, Italy, and written informed consent
was obtained from the parents or legal guardian of all
of the enrolled children.Methods
A previously prepared electronic chart was used to rec-
ord each enrolled child’s age, gender, height, weight, ges-
tational age, birth weight, respiratory complications at
birth, duration of breast-feeding, the number of siblings,
type of dwelling (i.e. urban or rural), household exposure
to cigarette smoke, age when starting day care atten-
dance, and the number and type of CAP episodes. We
also recorded any underlying diseases possibly associated
with CAP that had been diagnosed during hospitalisa-
tion or a visit to our outpatient clinic: i.e. oromotor in-
coordination and swallowing dysfunction predisposing
to aspiration syndrome [11]; immune disorders, includ-
ing atopy/allergy and primary and acquired immunodefi-
ciency syndrome [12,13]; congenital heart defects [14];
lung and airway problems such as chronic rhinosinusitis
with post-nasal drip [15], primary ciliary dyskinesia [16],
recurrent wheezing [17,18], bronchial asthma [13] or
middle lobe syndrome [19]; gastroesophageal reflux dis-
ease (GERD) [20]; and overweight or obesity [21].
Aspiration syndrome was diagnosed clinically and con-
firmed by means of fluoroscopic feeding studies showing
oropharyngeal incoordination. Immune function was de-
termined by measuring serum immunoglobulin levels,
IgG subclasses, T cell subpopulations, and complement
assays. Atopy was diagnosed in the presence of total IgE
levels of ≥2 standard deviations (SDs) for age and/or
allergen-specific IgE for common inhaled and food aller-
gens. The diagnoses of allergy were based on clinical
symptoms, skin tests and IgE determinations. Cardiac
anomalies were confirmed by means of echocardiog-
raphy. Chronic rhinosinusitis with post-nasal drip was
clinically diagnosed in the presence of at least two of the
following symptoms: a mucous or purulent nasal dis-
charge for more than three months, nasal congestion,
and posterior nasal drainage; in the case of doubt or the
frequent recurrence of pulmonary infections, flexible op-
tical fibre nasal endoscopy and/or paranasal sinus com-
puted tomography were used to confirm the diagnosis
and identify any mechanical obstructions of the upper
airways. Nasal ciliary function was evaluated by measu-
ring ciliary beat frequency in samples of ciliated epithe-
lium from the inferior nasal turbinate; in patients with
two pathological values, a further brushing was taken for
ultrastructural analysis by means of electron microscopy.
A diagnosis of suspected GERD was based on clinical
history and the assessment of symptoms such as regurgi-
tation, nausea, chest and/or abdominal pain, hoarseness
and dysphagia; when the diagnosis was doubtful, or in
the presence of refractory respiratory or gastrointestinal
manifestations, the children underwent a 24-hour intra-
esophageal pH study. The percentage of body fat was
calculated as the body mass index (BMI) SD in accord-
ance with the World Health Organisation child growth
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was defined as at least three episodes of respiratory tract
infections in a period of six months with parental re-
ports of shortness of breath and physician-diagnosed
dyspnea [17,18]. Bronchial asthma in school-age children
was diagnosed in the presence of at least two episodes of
wheezing, breathlessness, chest tightness, coughing, and
pulmonary function test evidence of airflow limitation.
Right middle lobe syndrome was defined as atelectasis
persisting for more than 4–6 weeks or two or more epi-
sodes of consolidation of the right middle lobe.
Statistical analysis
The continuous variables are given as mean values ±
SD and were compared between groups using a two-
sided Student’s t test after checking that the data were
normally distributed; and the categorical variables are
given as numbers and percentages and were compared
using contingency table analysis and the chi-squared or
Fisher’s test, as appropriate.
The odds ratios (ORs) of rCAP and corresponding 95%
confidence intervals (CIs) were computed using condi-
tional logistic regression, stratified by gender and age.
In further analyses, comparisons were made between
the children with rCAP (i.e. ≤3 episodes) and those with
hrCAP (i.e. >3 episodes). The hrCAP/rCAP ORs and CIs
were computed using unconditional multiple logistic re-
gression models, including terms for gender and age (<7
vs ≥7 years old: i.e. median values).
All of the tests were two-sided and a p value of <0.05
was considered statistically significant. The data were
analysed using SAS, version 9.1 (Cary, NC, USA).
Results and discussion
Table 1 shows the demographic characteristics of the 146
children with rCAP in DLAs and 145 controls enrolled in
the study. The two groups were comparable in terms of
gender and age distribution, the duration of breast-feeding,
the type of dwelling, exposure to cigarette smoke and the
number of siblings, but gestational age at birth (p = 0.003),
birth weight (p = 0.006), respiratory distress at birth (p <
0.001) and age when starting day care attendance (p =
0.001) were significantly different.
Table 2 shows the prevalence of possible predisposing
factors in the two groups. Severe predisposing factors
such as heart disease, oromotor incoordination and
swallowing dysfunction, ciliary dyskinesia, and primary
or acquired immunodeficiency were rare and never ob-
served in the controls, but were diagnosed before rCAP
in DLAs in the cases. Middle lobe syndrome was quite
frequent among the cases but never reported among
controls. GERD and obesity were relatively common in
both groups, but some conditions involving the respira-
tory tract were more frequent in the children with rCAP.Recurrent infectious wheezing was diagnosed in 113
cases (77.4%) and in only 20 controls (13.8%)(p < 0.001);
chronic rhinosinusitis with post-nasal drip was diag-
nosed in respectively 105 (71.9%) and six (4.1%) (p <
0.001); recurrent upper respiratory tract infections in 99
(67.8%) and 29 (20.0%) (p < 0.001); atopy/allergy in 75
(51.4%) and 17 (11.7%; p < 0.001); and asthma in 46
(31.5%) and eight (5.5%)(p < 0.001). The most important
predisposing factors were rhinosinusitis, recurrent
wheezing and asthma, which respectively increased the
risk of rCAP by about 60, 32 and 10 times.
Table 3 compares the patients with rCAP (≤3 epi-
sodes) and those with hrCAP (>3 episodes), and shows
that the significant risk factors for hrCAP were GERD
(p = 0.04), a history of atopy and/or allergy (p = 0.005), a
diagnosis of asthma (p = 0.0001), and middle lobe syn-
drome (p = 0.001); the last three were confirmed in the
multivariate logistic regression analysis adjusted for age
and gender, which also indicated that wheezing was as-
sociated with hrCAP.
To the best of our knowledge, this is the first study
carried out in an industrialised country evaluating the
prevalence of factors that are thought to be associated
with an increased risk of developing rCAP in DLAs in
children with or without rCAP. As some of the factors
associated with an increased risk of rCAP in DLAs are
very common pediatric diseases, this approach should
better define the real importance of each and simultan-
eously quantify the real weight of other potentially nega-
tive predisposing factors.
The study data suggest that children living in an
industrialised country with a history of rCAP in DLAs
can be divided into those suffering from a severe under-
lying disease that favours the development of CAP but
also causes other significant signs and symptoms that
frequently involve extra-respiratory sites, and those
whose clinical history is no different from that of many
children without rCAP. Some generally mild diseases
were frequent in both groups, although slightly more
among the cases; severe underlying diseases were fortu-
nately very rare and had already been identified before
they could cause rCAP. Heart disease, oromotor inco-
ordination and swallowing dysfunction predisposing to
aspiration syndrome, primary or acquired immunodefi-
ciency syndrome, and primary ciliary dyskinesia were
observed in very few cases, which indicates that the chil-
dren had been adequately diagnosed and treated from
their first months of life, thus significantly reducing the
risk of multiple CAP episodes. The same can probably
also be said of cystic fibrosis because neonatal screening
in Milan allows the early identification of the vast major-
ity of cases so that these patients were excluded. How-
ever, our findings are different from those of most other
studies of the potential causes of rCAP [3,7,8]. It has
Table 1 Demographic characteristics of the study population
Patients with rCAP % Healthy controls % Comparison between groups
(n = 146) (n = 145) p*
Gender
Female 73 50.0 73 50.0 0.95
Male 73 50.0 72 50.0
Age, mean ± SD (yrs) 7.9 ± 4.5 8.1 ± 4.5 0.70
Gestational age (weeks)
<32 11 7.5 0 0
32-36 18 12.3 17 11.7 0.003
≥37 117 80.2 128 88.3
Birth weight (g)
<750 3 2.1 0 0
750-1,000 1 0.7 0 0
1,001-1,500 7 4.8 0 0 0.006
1,501-2,500 14 9.6 7 4.8
>2500 121 82.8 138 95.2
Respiratory distress at birth
Yes 26 17.8 0 0 <0.001
No 120 82.2 145 100
Breast-feeding >3 months
Yes 83 58.4 85 58.6 0.94
No 59 41.6 60 41.4
Type of dwelling
Urban 127 87.0 124 85.5 0.72
Rural 19 13.0 21 14.5
Exposure to cigarette smoke
Yes 55 37.7 45 31.0 0.23
No 91 62.3 100 69.0
Number of siblings
0 48 32.9 45 31.0 0.08
1 66 45.2 74 51.0
2 26 17.8 26 17.9
≥3 6 4.1 0 0
Age starting day care attendance
≤1 year 14 9.6 0 0 <0.001
>13-23 months 24 16.4 2 1.4
24-35 months 33 22.6 40 27.6
36-47 months 64 43.8 103 71.0
≥4 years 11 7.5 0 0
rCAP: recurrent community-acquired pneumonia; SD: standard deviation. *P values were calculated using Student’s t test, the chi-squared test or Fisher’s test,
as appropriate.
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uncommon, may be unknown when a child with rCAP
is examined for the first time and, consequently, may
justify a more aggressive diagnostic approach in a large
number of subjects. Owayed et al. examined the clinicalrecords of 238 children with a history meeting the cri-
teria for rCAP, and found that 48% of them had aspir-
ation syndrome, 10% immune disorders and 9%
congenital heart disease [3]. Adam found that about half
of the children with rCAP that he studied had
Table 2 Predisposing factors associated with CAP recurrences in children with rCAP and controls, and corresponding








(n = 146) % (n = 145) % p°°
Predisposing factor
Heart disease
Yes 3 2.1 0 0 0.25 -
No 143 97.9 145 100.0
Oro-motor incoordination/swal-lowing
dysfunction
Yes 4 2.7 0 0 0.12 -
No 142 97.3 145 100.0
Primary ciliary dyskinesia
Yes 1 0.7 0 0 1.00 -
No 145 99.3 145 100.0
Primary or acquired immunodeficiency
Yes 2 1.4 0 0 0.50 -
No 144 98.6 145 100.0
GERD
Yes 31 21.2 20 13.8 0.69 1.33 (0.64-2.80)
No 115 78.8 125 86.2 1§§
Overweight/obesity
BMI SD <1 112 76.7 119 82.1 0.76 1§§
BMI SD ≥1 34 23.3 26 17.9 1.34 (0.58-1.97)
Wheezing
Yes 113 77.4 20 13.8 <0.001 32.00 (10.14-
100.96)
No 33 22.6 125 86.2 1§§
Chronic rhinosinusitis with post-nasal drip
Yes 105 71.9 6 4.1 <0.001 59.33 (24.48-
144.97)
No 41 28.1 139 95.9 1§§
Middle lobe syndrome
Yes 44 30.1 0 0
No 102 69.9 145 100.0 <0.001 -
Recurrent upper respiratory tract infections
Yes 99 67.8 29 20.0 <0.001 6.75 (3.68-12.37)
No 47 32.2 116 80.0 1§§
Atopy/allergy
Yes 75 51.4 17 11.7 <0.001 7.44 (3.71-14.93)
No 71 48.6 128 88.3 1§§
Asthma
Yes 46 31.5 8 5.5 <0.001 10.50 (3.77-29.28)
No 100 68.5 137 94.5 1§§
CI: confidence interval; BMI SD: body mass index standard deviation; GERD: gastroesophageal reflux diseae; OR: odds ratio. °°Chi-squared or Fisher’s test, as
appropriate; rCAP: recurrent community-acquired pneumonia. §ORs from conditional logistic regression model, stratified by gender and age.§§reference category.
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Table 3 Comparison of predisposing factors between children with rCAP (≤3) and those with hrCAP (>3 CAP)
Predisposing factor ≤3 CAP >3 CAP Comparison between groups OR (95% CI)§
Total (n = 71) % Total (n = 75) % p°
GERD
Yes 10 14.1 21 28.0 0.04 2.34 (0.07-5.69)
No 61 85.9 54 72.0 1§§
Overweight/obesity
BMI SD <1 58 81.7 54 72.0 0.53 1§§
BMI SD ≥1 13 18.3 21 28.0 2.18 (0.53-8.91)
Wheezing
Yes 51 71.8 62 82.7 0.056 2.43 (1.02-5.79)
No 20 28.2 13 17.3 1§§
Chronic rhinosinusitis with post nasal drip
Yes 46 64.8 59 78.7 0.06 1.97 (0.91-4.27)
No 25 35.2 16 21.3 1§§
Middle lobe syndrome
Yes 12 16.9 32 42.7 3.02 (1.36-6.71)
No 59 83.1 43 57.3 <0.001 1§§
Recurrent upper respiratory tract infections
Yes 47 66.2 52 69.3 0.69 1.33 (0.64-2.80)
No 24 33.8 23 30.7 1§§
Atopy/allergy
Yes 28 39.4 47 62.7 0.005 2.20 (1.10-4.42)
No 43 60.6 28 37.3 1§§
Asthma
Yes 11 15.5 35 46.7 <0.001 3.46 (1.48-8.08)
No 60 84.5 40 53.3 1§§
CI: confidence interval; BMI SD: body mass index standard deviation; GERD: gastroesophageal reflux disease; OR: odds ratio; °Chi-squared test; §estimates from
multiple logistic regression models, including terms for gender and age (<7 vs ≥7 years old, median values); §§reference category.
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other retrospective study investigating the cause of rCAP
in 70 Indian children found that the most frequent ill-
ness was recurrent aspiration, followed by immunodefi-
ciency [7], and a more recent Spanish study found that
congenital cardiac defects and aspiration syndrome were
the most represented illnesses [8]. However, most of
these studies were carried out some years ago and some
were conducted in the developing world, where there is
still a lack of basic services, high morbidity and mortality
rates, and where the identification of severe underlying
diseases leading to rCAP is regularly delayed.
Unlike severe diseases, mild to moderate respiratory in-
fections were significantly more frequent in our children
with rCAP, which seemed to be significantly associated
with wheezing, chronic rhinosinusitis with postnasal drip,
atopy/allergy and asthma. Recurrent respiratory tract infec-
tions are common in otherwise healthy children during the
first years of life [23] because of the relative immaturity of
the immune system, and they can lead to more severedisease in atopic and allergic children, and those with
wheezing or asthma [23-25]. Most of our patients with
rCAP in DLAs were simultaneously affected by all of these
conditions, which suggests that the concurrence of several
factors simply increased the clinical evidence of a natural
phenomenon but had no particular clinical implication.
Consequently, such children only need to undergo the pre-
ventive and therapeutic measures usually prescribed for re-
current respiratory infections and wheezing.
Although chronic rhinosinusitis with post-nasal drip is a
common childhood disease [26,27], it is not usual to exa-
mine the upper airways and seek a purulent discharge in-
side the nasal cavities in children with a history of rCAP.
However, on the basis of our results, it is important to start
thinking in terms of nose-lung interactions as in the case
of the relationship between allergic rhinitis and asthma
[28]. The relevance of asthma as a possible cause of rCAP
has been reported by a number of authors, and seems
to be strictly related to the quality of asthma control
[17,28,29]. The lung function of children whose asthma is
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they experience very few (if any) lower respiratory tract
infections. Consequently, they do not need a particularly
aggressive diagnostic approach and should simply be pre-
scribed adequate asthma prophylactic therapy. A limitation
of our study is represented by the absence of etiologic data
on CAP episodes reported in the study population. It is
possible that a proportion of children presenting with CAP
have had a viral rather than bacterial cause of rCAP. Viral
infections have been frequently associated with atopy,
asthma and allergy [30,31] and these viral infections could
explain our findings. However, also CAP due to atypical as
typical bacteria can be associated with asthma [18,32,33].
In the case of right middle lobe syndrome associated
with hrCAP, our data support the prompt use of physio-
therapy with a positive pressure mask in order to aid re-
gional lung clearance and avoid CAP recurrences [34].
Some authors have found a relationship between right
middle lobe syndrome and asthma [34,35] but the small
number of patients in our series prevents us from
confirming or refuting this finding.
We did not find that GERD increased the risk of rCAP,
although it may be associated with more frequent recur-
rences. This is not in line with the findings of some uncon-
trolled studies [3,7,9] but as GERD is a common disease, it
is possible that the observed relationship was only casual.
In any case, GERD can be easily diagnosed on the basis of
gastrointestinal complaints and treated without any further
laboratory or radiological investigations.
Our findings indicate that prematurity, a low birth
weight and respiratory distress at birth are independent
factors associated with rCAP. The widely reported import-
ance of chronic respiratory morbidity in prematurely born
infants is due to their smaller and hyper-responsive airways
[36-38], and there is also evidence that they may also have
a genetic predisposition to viral infections [39], a com-
bination that can facilitate catarrhal obstruction of the
airways and lung inflammation. Up to 73% of pre-term
infants with pulmonary bronchodysplasia require re-
admission to hospital because of lower respiratory tract
diseases in the first years of life, and chronic res-
piratory morbidity requiring the use of healthcare facil-
ities remains even at school age [40]. It should be
investigated whether, in addition to adequate vaccinations,
all pre-term babies and those with respiratory distress at
birth would benefit from regular chest physiotherapy
during respiratory illnesses in order to enhance secre-
tion mobilisation and prevent recurrent infections.
Moreover, as most of our children with rCAP were al-
lergic and asthmatic, our finding that early day care at-
tendance seemed to protect against rCAP supports the
idea that the so-called “hygiene hypothesis” (i.e. expo-
sure to a wide variety of pathogens protects against
atopy and asthma) might also apply to rCAP [41].Conclusions
In brief, our findings show that the diagnostic approach
to children with rCAP in DLAs used in the developed
world is relatively easy in most cases, and the severe
underlying diseases favouring rCAP are usually identified
early. Furthermore, when episodes of rCAP in DLAs do
occur, an adequate evaluation of the patient’s history and
clinical findings is usually sufficient. Except for prema-
turity, the factors predisposing children to develop rCAP
in DLAs are of limited clinical importance and do not
need any particular diagnostic measures. Wheezing,
chronic rhinosinusitis with postnasal drip, atopy/allergy
and asthma seem to be the main factors associated with
CAP recurrences and, in their presence, children with
rCAP can be followed up by means of the same proce-
dures as those usually used in the case of children with-
out rCAP. Our findings have relevance in terms of
informing future research on potential risk factors for
recurrent CAP, although a more complicated approach
is needed in the third world, where the early identifica-
tion of the severe underlying diseases favouring rCAP is
significantly more difficult or even impossible.
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